Adial Pharmaceuticals, Inc. Shareholders' Equity
Adial Pharmaceuticals, Inc. (ADIL) had Shareholders' Equity of -$38.38 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$38.38M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $3.72M; Stockholders' Equity Attributable to Parent as first filed $3.72M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $5.28M; Stockholders' Equity Attributable to Parent as first filed $5.28M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $4.51M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$38.38M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.72M 10-Q · filed 2026-08-14 | $3.72M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $5.28M 10-Q · filed 2026-08-14 | $5.28M 10-K · filed 2026-03-05 |
| 2025-09-30 | $4.51M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.59M 10-Q · filed 2026-08-14 | $5.59M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $2.13M 10-Q · filed 2026-08-14 | $2.13M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $4.07M 10-Q · filed 2026-08-14 | $4.07M 10-K · filed 2025-03-04 |
| 2024-09-30 | $5.88M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $4.28M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $6.12M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $4.08M 10-K · filed 2026-03-05 | |
| 2023-09-30 | $2.34M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $3.32M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $1.44M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $3.28M 10-K · filed 2025-03-04 | |
| 2022-09-30 | $5.41M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $7.96M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $10.71M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $3.51M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $7.20M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $4.83M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $5.62M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $3.99M 10-K · filed 2023-03-30 | |
| 2020-09-30 | $7.09M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $8.79M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $5.55M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $7.14M 10-K · filed 2022-03-28 | |
| 2019-09-30 | $8.73M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $10.06M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | $11.73M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $4.44M 10-K · filed 2021-03-22 | |
| 2018-09-30 | $4.93M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | -$1.29M 10-Q · filed 2019-11-14 | |
| 2018-03-31 | -$1.31M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | -$997.55K 10-K · filed 2020-03-20 | |
| 2016-12-31 | -$103.49K 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |